Explore advancements in health tech, medical research, and the innovations enhancing global healthcare.
The NIH has launched a new autoimmune disease initiative aimed at coordinating research, improving data and tools, and accelerating progress across conditions that affect tens of millions of...
Daraxonrasib is designed to target KRAS-driven pancreatic tumors, a long-standing challenge in drug development. Early clinical results point to longer survival and renewed momentum for KRAS-focused...
An experimental approach tested in a small liver transplant trial helped some recipients stay off standard anti-rejection drugs for years, raising new questions about how transplant tolerance could...
A Case Western Reserve University study links certain gut bacteria and microbe-made sugars to immune reactions that may worsen ALS and frontotemporal dementia, offering a new angle on why genetic...
Researchers are developing tiny, encapsulated insulin-producing cell implants designed to act like a mini pancreas. The approach aims to reduce or eliminate insulin injections while avoiding immune...
UCL-led researchers report that the protein LRG1 can trigger early diabetic retinopathy by constricting tiny retinal vessels and reducing oxygen. Mouse studies suggest blocking LRG1 may protect...
Researchers mapped the genetic programs that steer CD8 "killer" T cells toward long-lasting activity or exhaustion, pointing to new ways to sustain immune attacks against tumors and improve...
A team in China reports a new way to manufacture natural killer (NK) immune cells by engineering early-stage cord-blood stem cells, aiming to make NK-cell cancer immunotherapy more consistent and...
A University of Michigan team reports an AI system that can identify more than 50 brain disorders from MRI scans in seconds, reaching up to 97.5% accuracy in testing and pointing to faster clinical...
A new MIT-led study suggests temporarily silencing retinal activity can reopen the brain's learning window for vision, improving amblyopia in animal tests and hinting at future non-surgical therapies.
An experimental sepsis drug from Griffith University researchers showed encouraging Phase II results in 180 patients in China, aiming to calm the immune overreaction that can drive organ failure.
A preclinical study suggests a three-drug combination can overcome tumour resistance in pancreatic cancer, triggering complete and lasting regression in animal models and highlighting a new way to...
Researchers are exploring if combining high-intensity interval training with anti-inflammatory medications can delay aging and prevent age-related diseases. Discover the science behind this...
Oscar Murphy, battling aggressive leukaemia, becomes the first UK patient to undergo revolutionary CAR-T therapy on the NHS, offering new hope for blood cancer treatment.
Discover how a breakthrough optical gradient acquisition method enables rapid, high-resolution wavefront shaping for deep tissue imaging, vastly outperforming previous techniques.